BRIEF-Repros Therapeutics jumps in premarket after testosterone drug hits main goals of study
March 28, 2013 at 08:10 AM EDT
NEW YORK, March 28 (Reuters) - Repros Therapeutics Inc : * Jumps 75.3 to $16 in premarket after testosterone drug hits main goals of study